相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells
Visish M. Srinivasan et al.
JOURNAL OF NEUROSURGERY (2020)
Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies
Tae-Eun Park et al.
NATURE COMMUNICATIONS (2019)
First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound
Agessandro Abrahao et al.
NATURE COMMUNICATIONS (2019)
Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis
Nagham Kaka et al.
CANCERS (2019)
Blood-Brain Barrier Opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: A Clinical Safety and Feasibility Study
Todd Mainprize et al.
SCIENTIFIC REPORTS (2019)
HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance
Sonia Pernas et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects
Mariana Brandao et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial
Yongteng Xu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Novel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs
Nan Jiang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives
Nuria Kotecki et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Apparent diffusion coefficient changes predict survival after intra-arterial bevacizumab treatment in recurrent glioblastoma
Naveen Galla et al.
NEURORADIOLOGY (2017)
Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury
Anwarul Hasan et al.
FRONTIERS IN NEUROLOGY (2017)
Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival
Gaelle Mueller-Greven et al.
CLINICAL CANCER RESEARCH (2017)
Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity
Leslie L. Muldoon et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Analysis of risk and predictors of brain radiation necrosis after radiosurgery
Hongqing Zhuang et al.
ONCOTARGET (2016)
Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy
R. Singh et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study
Shamik Chakraborty et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Frequent BRAF or EGFR Mutations in Ciliated Muconodular Papillary Tumors of the Lung
Tsugumasa Kamata et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier
Eric C. Leuthardt et al.
PLOS ONE (2016)
Intraarterial drug delivery for glioblastoma mutiforme
Shailendra Joshi et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain
Shervin R. Dashti et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2015)
Cerebral Hypoperfusion-Assisted Intra-arterial Deposition of Liposomes in Normal and Glioma-Bearing Rats
Shailendra Joshi et al.
NEUROSURGERY (2015)
Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints
Hong Jiang et al.
CURRENT OPINION IN VIROLOGY (2015)
Intraarterial chemotherapy as the first-line therapy in penile cancer
P-H Chiang et al.
BRITISH JOURNAL OF CANCER (2014)
The role of intra-arterial chemotherapy as an adjuvant treatment for glioblastoma
Christian Theodotou et al.
BRITISH JOURNAL OF NEUROSURGERY (2014)
Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and percutaneous hepatic perfusion
Omar M. Rashid et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Intra-arterial carboplatin as a salvage strategy in the treatment of recurrent glioblastoma multiforme
David Fortin et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Transient cerebral hypoperfusion assisted intraarterial cationic liposome delivery to brain tissue
Shailendra Joshi et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Feasibility of Delivering Mesenchymal Stem Cells Via Catheter to the Proximal End of the Lesion Artery in Patients With Stroke in the Territory of the Middle Cerebral Artery
Yongjun Jiang et al.
CELL TRANSPLANTATION (2013)
Intra-Arterial Chemotherapy Is Not Superior to Intravenous Chemotherapy for Malignant Gliomas: A Systematic Review and Meta-Analysis
Weifeng Chen et al.
EUROPEAN NEUROLOGY (2013)
Challenges With the Diagnosis and Treatment of Cerebral Radiation Necrosis
Samuel T. Chao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Main complications and results of treatment with intra-arterial infusion chemotherapy through the subclavian and thoracic arteries for locally advanced breast cancer
Xiaoyi Wang et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Metabolic Response of Glioblastoma to Superselective Intra-Arterial Cerebral Infusion of Bevacizumab: A Proton MR Spectroscopic Imaging Study
J. Y. Jeon et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
A Randomized Trial of Mesenchymal Stem Cells in Multiple System Atrophy
Phil Hyu Lee et al.
ANNALS OF NEUROLOGY (2012)
Experience of intra-arterial chemosurgery with single agent carboplatin for retinoblastoma
Jasmine H. Francis et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Temporary Disruption of the Blood-Brain Barrier by Use of Ultrasound and Microbubbles: Safety and Efficacy Evaluation in Rhesus Macaques
Nathan McDannold et al.
CANCER RESEARCH (2012)
Orthotopic glioblastoma stem-like cell xenograft model in mice to evaluate intra-arterial delivery of bevacizumab: From bedside to bench
Jan-Karl Burkhardt et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Superselective Intra-Arterial Cerebral Infusion of Novel Agents After Blood-Brain Disruption for the Treatment of Recurrent Glioblastoma Multiforme: A Technical Case Series
Benjamin J. Shin et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2012)
Bringing the Endovascular Neurosurgeon into the Neuro-oncology Treatment Team
Pierpaolo Peruzzi et al.
WORLD NEUROSURGERY (2012)
Intra-Arterial Delivery of Bevacizumab after Blood-Brain Barrier Disruption for the Treatment of Recurrent Glioblastoma: Progression-Free Survival and Overall Survival
Jan-Karl Burkhardt et al.
WORLD NEUROSURGERY (2012)
RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF BEVACIZUMAB THERAPY FOR RADIATION NECROSIS OF THE CENTRAL NERVOUS SYSTEM
Victor A. Levin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases
Motomasa Furuse et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma Clinical article
John A. Boockvar et al.
JOURNAL OF NEUROSURGERY (2011)
Noninvasive, Transient and Selective Blood-Brain Barrier Opening in Non-Human Primates In Vivo
Fabrice Marquet et al.
PLOS ONE (2011)
Super-Selective Basilar Artery Infusion of Bevacizumab and Cetuximab for Multiply Recurrent Pediatric Ependymoma
P. Rajappa et al.
INTERVENTIONAL NEURORADIOLOGY (2011)
Balloon-Assisted Superselective Intra-Arterial Cerebral Infusion of Bevacizumab for Malignant Brainstem Glioma A Technical Note
H. A. Riina et al.
INTERVENTIONAL NEURORADIOLOGY (2010)
Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience
Lilyana Angelov et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
Teri N. Kreisl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bevacizumab and irinotecan in the treatment of recurrent malignant gliomas
John F. de Groot et al.
CANCER JOURNAL (2008)
Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: Interim analysis of safety and tolerability
Albert Lai et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells
Hemant Sarin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Strategies to advance translational research into brain barriers
Edward Neuwelt et al.
LANCET NEUROLOGY (2008)
Glioma extent of resection and its impact on patient outcome
Nader Sanai et al.
NEUROSURGERY (2008)
A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma - Initial results
David H. Abramson et al.
OPHTHALMOLOGY (2008)
Transient cerebral hypoperfusion enhances intraarterial carmustine deposition into brain tissue
Shailendra Joshi et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: Role of autophagic, cell death
Hong Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Chemotherapy delivery issues in central nervous system malignancy: A reality check
Leslie L. Muldoon et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A perivascular niche for brain tumor stem cells
Christopher Calabrese et al.
CANCER CELL (2007)
Chemotherapy in the treatment of malignant gliomas
Jennifer I. Stem et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas
Walter A. Hall et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy
WB Pope et al.
NEUROLOGY (2006)
Cerebral blood flow affects dose requirements of intracarotid propofol for electrocerebral silence
S Joshi et al.
ANESTHESIOLOGY (2006)
HER2 therapy - Molecular mechanisms of trastuzumab resistance
Rita Nahta et al.
BREAST CANCER RESEARCH (2006)
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: The sherbrooke experience
D Fortin et al.
CANCER (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
JS Barnholtz-Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas
HB Newton et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Intraarterial chemotherapy for brain tumors by using a spatial dose fractionation algorithm and pulsatile delivery
YP Gobin et al.
RADIOLOGY (2001)
Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures
AI Qureshi et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer
D Kirn
ONCOGENE (2000)
Treatment for primary CNS lymphoma: The next step
LE Abrey et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma
E Zylber-Katz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
分享论文
